Where is Chunghwa Holding's main operation in China?

Its primary facility is Suzhou Chunghwa Pharmaceutical Industry Co., Ltd. located in Suzhou, Jiangsu Province.

Does this board change indicate management instability?

No, this is a routine replacement by the legal shareholder, indicating stable governance continuity.

Is Chunghwa Holding listed on any stock exchange?

It is likely listed on Taiwan's GreTai Securities Market (TPEx).

What products does Suzhou Chunghwa Pharmaceutical manufacture?

It mainly produces prescription drugs, OTC medicines, and pharmaceutical chemicals.

How might this change affect investors?

This governance refresh is seen as a positive long-term signal for corporate value enhancement.

[Chunghwa Holding] Announcement of New Legal Person Director and…

Published Sep 23, 2026 9:00 AM ・ Updated Sep 24, 2026 5:25 PM ・ 4 min read ・ Source: PR Times

Chunghwa Holding Co., Ltd. has announced the appointment of new legal representative directors for its subsidiary, Suzhou Chunghwa Pharmaceutical Industry Co., Ltd., effective September 23, 2026. The board sees over one-third turnover within the same term, qualifying as a material corporate announcement.

1. Date of Change: 115/09/23

2. Category of Appointed or Changed Personnel (Legal Person Director, Legal Person Supervisor, Independent Director, Natural Person Director, or Natural Person Supervisor): Legal Person Director

3. Former Title and Name: CHUNGHWA HOLDING CO.,LTD Representative: Huang Yi-Chun CHUNGHWA HOLDING CO.,LTD Representative: Sun Ye CHUNGHWA HOLDING CO.,LTD Representative: Wang Hou-Jie

4. Former's Resume: Corporate Governance Officer, Chunghwa Holding Co., Ltd. Vice General Manager, Suzhou Chunghwa Pharmaceutical Industry Co., Ltd. Director, Chunghwa Holding Co., Ltd.

5. New Title and Name: CHUNGHWA HOLDING CO.,LTD Representative: Lin Cheng-Yu CHUNGHWA HOLDING CO.,LTD Representative: Li Wei CHUNGHWA HOLDING CO.,LTD Representative: Mao Wei

6. New's Resume: Section Chief, Chunghwa Holding Co., Ltd. Vice General Manager, Suzhou Chunghwa Pharmaceutical Industry Co., Ltd. Director, Suzhou Chunghwa Pharmaceutical Industry Co., Ltd.

7. Nature of Change (Please enter 'Resignation', 'Dismissal', 'End of Term', 'Deceased', or 'New Appointment'): New Appointment

8. Reason for Change: Replacement of legal representative

9. Number of Shares Held by New Appointee at Time of Election: Not applicable

10. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): Not applicable

11. Effective Date of New Appointment: 115/09/23

12. Proportion of Directors Changed During Same Term: 3/7

13. Proportion of Independent Directors Changed During Same Term: Not applicable

14. Proportion of Supervisors Changed During Same Term: Not applicable

15. Is it a change involving more than one-third of directors? (Yes or No): Yes

16. Other Matters to be Clarified (If the subject of the event or resolution is a publicly issued company or above, this major information also meets the criteria under Article 7, Paragraph 6 of the Enforcement Rules of the Securities Trading Act regarding matters significantly affecting shareholders' rights or securities prices): None

FACT BOX

Source: PR Times
Category: 人事
Dates in source: 115/09/23

[Chunghwa Holding] Announcement of New Legal Person Director and Over One-Third Board Change for Subsidiary 'Suzhou Chunghwa Pharmaceutical Industry Co., Ltd.'

⚡ Key Points

FACT BOX

Editorial & Verification Standards

FAQ

Cite this article — HOW TO CITE

AI CRAWLER ACTIVITY